Polymyxin B Inactivation of Lipopolysaccharide in Vaccines of Gram-Negative Bacteria
AUTOR(ES)
Cooperstock, Michael
RESUMO
Endotoxin activity in suspensions of Bordetella pertussis, Escherichia coli, Haemophilus influenzae, and Pseudomonas aeruginosa was often markedly decreased by polymyxin B. Polymyxin B treatment may be a means to reduce inflammatory reactivity of lipopolysaccharide in vaccines of gram-negative bacteria.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=350693Documentos Relacionados
- Susceptibility of gram-negative bacteria to polymyxin B nonapeptide.
- Binding of polymyxin B nonapeptide to gram-negative bacteria.
- Interaction of Complement and Polymyxin with Gram-Negative Bacteria
- Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria
- Combined Activity of Sulfamethoxazole, Trimethoprim, and Polymyxin B Against Gram-Negative Bacilli
